Europe Blood Glucose Monitoring System Market – Industry Analysis and Forecast (2022-2029)

Europe Blood Glucose Monitoring System Market size is expected to grow at a CAGR of 11.20% during the forecast period and the market size is expected to reach nearly US$ 7.64 Bn. by 2029. Blood glucose monitoring, in other words, means testing concentration of glucose within blood also known as glycaemia. Generally, a blood glucose test is done by piercing the fingertip with the help of a needle, post which the blood is collected over a chemically active strip that gives the reading of the glucose amount present within the blood. Manufacturers opt for different systems based on demand and utilities as well.Europe Blood Glucose Monitoring System MarketTo know about the Research Methodology:-Request Free Sample Report Blood glucose meters are used for measuring and monitoring glucose level. It is a small device that is portable and can be used anywhere with the only requirement of strips. Advanced versions of these glucose meters also help in determining the type of glucose which further help patients to monitor diabetes in a better way. Cost-efficiency along with the timely availability of data have been other important factors that have led to high demand of blood glucose monitoring machines. The product, testing type, patient care setting, application, and geography have formed different segments based on which Europe blood glucose monitoring system is divided. On the basis of product, the market has been segmented into self-monitoring and continuous monitoring devices. Self-monitoring devices have held a larger market share with factors as growing health awareness, easier availability of products along faster monitoring of data without the need for any doctors acting as some of the major drivers for this market. The market has been further divided into the testing type that comprises the fingertip and alternate site testing. Fingertip held a larger market share with more number of people still following the traditional way of testing. It is easier as well and can be done more quickly as compared to alternate sites for diabetes testing. Patient care setting for this market has been dome by taking into consideration homecare and hospitals. Homecare held a larger market share with the growing number of the geriatric population being self-sufficient in monitoring their diabetes. Diabetes 2 have held a larger market share in the application segment as there has been growing awareness about diabetes and advanced medical options available as well. Europe has some of the largest pharmaceutical companies that are working to deliver advanced glucose monitoring systems for patients. Diabetes is expected to encompass more than 90% of the population across all age group in the next 20 years, which has alarmed the need for bringing a timely diagnosis of this disease.

Europe Blood Glucose Monitoring System Market, Key Highlights:

• Europe Blood Glucose Monitoring System market size analysis and forecast • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the Europe Blood Glucose Monitoring System market • Blood Glucose Monitoring System market segmentation on the basis of product, testing type, patient care setting, application, and geography. • Blood Glucose Monitoring System market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study • Blood Glucose Monitoring System market analysis and forecast for major countries has been provided. • Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies • Competitive landscape of the key players operating in the Blood Glucose Monitoring System market including competitive developments, investments, and strategic expansion

Europe Blood Glucose Monitoring System Market Research Methodology

The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for Europe Blood Glucose Monitoring System market

Europe Blood Glucose Monitoring System Market, Key Target Audience:

• Blood glucose monitoring systems and related devices manufacturers • Hospitals, diagnostic centers, homecare service providers, and medical colleges • Teaching hospitals and academic medical centers • Suppliers and distributors of blood glucose monitoring systems • Government bodies or municipal corporations

Europe Blood Glucose Monitoring System Market Scope: Inquire before buying

Europe Blood Glucose Monitoring System Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 3.27 Bn.
Forecast Period 2022 to 2029 CAGR: 11.20% Market Size in 2029: US $ 7.64 Bn.
Segments Covered: by Product • Self-Monitoring Blood Glucose Systems • Blood Glucose meters • Testing strips • Lancets & Lancing Devices • Continuous Glucose Monitoring Systems • Sensors • Transmitters • Receivers
by Testing Site • Fingertip testing • Alternate Site Testing
by Patient Care Setting • Self/Home Care • Hospital & Clinics
by Application • Type 2 Diabetes • Type 1 Diabetes • Gestational Diabetes

Europe Blood Glucose Monitoring System Market, by Region:

• Europe • UK • Germany • Russia • Italy • France • Spain • Others

Europe Blood Glucose Monitoring System Market, Region Analysis

• Breakdown of UK Blood Glucose Monitoring System market • Breakdown of Germany Blood Glucose Monitoring System market • Breakdown of Russia Blood Glucose Monitoring System market • Breakdown of Italy Blood Glucose Monitoring System market • Breakdown of France Blood Glucose Monitoring System market • Breakdown of Spain Blood Glucose Monitoring System market • Breakdown of Others Blood Glucose Monitoring System market

Europe Blood Glucose Monitoring System Market Key Players

Roche • Ascensia • Medtronic • Ypsomed • B. Braun Melsungen • Sanofi • Abbott Laboratories • Merck • Bayer • Astra Zeneca

Frequently Asked Questions:

1. Which region has the largest share in Europe Blood Glucose Monitoring System Market? Ans: UK held the highest share in 2021. 2. What is the growth rate of Europe Blood Glucose Monitoring System Market? Ans: The Europe Blood Glucose Monitoring System Market is expected to grow at a CAGR of 11.20% during forecast period 2022-2029. 3. What is scope of the Europe Blood Glucose Monitoring System market report? Ans: Europe Blood Glucose Monitoring System Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Europe Blood Glucose Monitoring System market? Ans: The important key players in the Europe Blood Glucose Monitoring System Market are – Roche, Ascensia, Medtronic, Ypsomed, B. Braun Melsungen, Sanofi, Abbott Laboratories, Merck, Bayer, and Astra Zeneca 5. What is the study period of this market? Ans: The Europe Blood Glucose Monitoring System Market is studied from 2021 to 2029.

Europe Blood Glucose Monitoring System Market

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET VARIABLES SCOPE 3.1. Market Segmentation Scope 3.2. Market Driver Analysis 3.3. Market Restraint Analysis 3.4. Penetration Growth Prospect Mapping 3.5. Market SWOT Analysis, By Factor (political legal, economic and technological) 3.6. Porter’s Five Forces Industry Analysis 3.7. Market Value Chain Analysis 4. PRODUCT ESTIMATES TREND ANALYSIS (2021-2029) 4.1. Blood Glucose Monitoring System Market: Product Analysis 4.2. Self-Monitoring Blood Glucose Systems 4.2.1. Self-Monitoring Blood Glucose Systems market, 2021-2029(USD billion) 4.3. Continuous Glucose Monitoring Systems 4.3.1. Continuous Glucose Monitoring Systems market, 2021-2029(USD billion) 5. TESTING SITE ESTIMATES TREND ANALYSIS (2021-2029) 5.1. Blood Glucose Monitoring System Market: Testing Site Analysis 5.2. Fingertip 5.2.1. Fingertip market, 2021-2029(USD billion) 5.3. Alternate Site 5.3.1. Alternate Site market, 2021-2029(USD billion) 6. PATIENT CARE SETTING ESTIMATES TREND ANALYSIS (2021-2029) 6.1. Blood Glucose Monitoring System Market: Patient Care Setting Analysis 6.2. Self/Home Care 6.2.1. Self/Home Care market, 2021-2029(USD billion) 6.3. Hospital Clinics 6.3.1. Hospital Clinics market, 2021-2029(USD billion) 7. APPLICATION ESTIMATES TREND ANALYSIS (2021-2029) 7.1. Blood Glucose Monitoring System Market: Application Analysis 7.2. Type 2 Diabetes 7.2.1. Type 2 Diabetes market, 2021-2029(USD billion) 7.3. Type 1 Diabetes 7.3.1. Type 1 Diabetes market, 2021-2029(USD billion) 7.4. Gestational Diabetes 7.4.1. Gestational Diabetes market, 2021-2029(USD billion) 8. REGIONAL ESTIMATES TREND ANALYSIS BY PRODUCT, TESTING TYPE, PATIENT CARE SETTING AND APPLICATION (2021-2029) 8.1. Blood Glucose Monitoring System market share by country, 2021-2029 8.2. UK 8.2.1. UK Blood Glucose Monitoring System market, 2021-2029(USD billion) 8.3. Germany 8.3.1. Germany Blood Glucose Monitoring System market, 2021-2029(USD billion) 8.4. Italy 8.4.1. Italy Blood Glucose Monitoring System market, 2021-2029(USD billion) 8.5. France 8.5.1. France Blood Glucose Monitoring System market, 2021-2029(USD billion) 8.6. Russia 8.6.1. Russia Blood Glucose Monitoring System market, 2021-2029(USD billion) 8.7. Spain 8.7.1. Spain Blood Glucose Monitoring System market, 2021-2029(USD billion) 8.8. Others 8.8.1. Others Blood Glucose Monitoring System market, 2021-2029(USD billion) 9. MARKET COMPETITION ANALYSIS 9.1. Strategy Framework 9.2. Company Profiles 9.2.1. Roche Diagnostics 9.2.1.1. Company Overview 9.2.1.2. Financial Performance 9.2.1.3. Product Benchmarking 9.2.1.4. Strategic Initiatives 9.2.2. Ascensia 9.2.2.1. Company Overview 9.2.2.2. Financial Performance 9.2.2.3. Product Benchmarking 9.2.2.4. Strategic Initiatives 9.2.3. Medtronic 9.2.3.1. Company Overview 9.2.3.2. Financial Performance 9.2.3.3. Product Benchmarking 9.2.3.4. Strategic Initiatives 9.2.4. Ypsomed 9.2.4.1. Company Overview 9.2.4.2. Financial Performance 9.2.4.3. Product Benchmarking 9.2.4.4. Strategic Initiatives 9.2.5. B. Braun Melsungen 9.2.5.1. Company Overview 9.2.5.2. Financial Performance 9.2.5.3. Product Benchmarking 9.2.5.4. Strategic Initiatives 9.2.6. Sanofi 9.2.6.1. Company Overview 9.2.6.2. Financial Performance 9.2.6.3. Product Benchmarking 9.2.6.4. Strategic Initiatives 9.2.7. Abbott Laboratories 9.2.7.1. Company Overview 9.2.7.2. Financial Performance 9.2.7.3. Product Benchmarking 9.2.7.4. Strategic Initiatives 9.2.8. Merck 9.2.8.1. Company Overview 9.2.8.2. Financial Performance 9.2.8.3. Product Benchmarking 9.2.8.4. Strategic Initiatives 9.2.9. Bayer 9.2.9.1. Company Overview 9.2.9.2. Financial Performance 9.2.9.3. Product Benchmarking 9.2.9.4. Strategic Initiatives 9.2.10. Astra Zeneca 9.2.10.1. Company Overview 9.2.10.2. Financial Performance 9.2.10.3. Product Benchmarking 9.2.10.4. Strategic Initiatives
  • INQUIRE BEFORE BUYING